Red wine-based drug may help curb obesity, diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking resveratrol-based SRT1720 drugs did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The drug has also extended the life span of mice in the junk food group by up to 44%. The findings suggest that drugs based on resveratrol, commonly found in red wines, may address obesity, diabetes, heart disease and cancer, experts said.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA